Effects of 5-aza-2′-deoxy city dine on proliferation of glioma cell lines and abnormal methylation of LRRC4 Gene

Progress in Biochemistry and Biophysics

Volumn 36, Issue 7, 2009, Pages 904-909

  Zhang, Zu Ping ^a,b   Wu, Ming Hua ^a   Tang, Hai Lin ^a   Wang, Rong ^a   Li, Dan ^a   Li, Xiao Ling ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

5 aza Cdr; DNA methylation; Glioma cell lines; LRRC4 gene

Indexed keywords

EID: 70350677139     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00811     Document Type: Article

References (15)

1. Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 2003, 349 (21): 2042-2054 (Pubitemid 37448928)
2. Wu M H, Li X L, Li G Y. Prog Biochem Biophys, 2007, 34(12): 1234-1239
3. Wu M H, Li X L, Huang C, et al. J Cent South Univ (Med Sci), 2007, 32(2): 231-234
4. Wang J R. Idenrtification and functional study of LRRC4, a novel brain-specific gene on chromosome7q31-32: [thesis]. Changsha: Xiang Ya School of Medicine, Central South University, 2002
5. Bird A. DNA methylation patterns and epigenetic memory. Nat Dev, 2002, 16(1): 6-21 (Pubitemid 34049633)
6. Esteller M. Epigenetics in cancer. N Engl J Med, 2008, 358(11): 1148-1159
7. Merlo A, Herman J G, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor P16/CDKN2/MTS1 in human cancers. Nat Med, 1995, 1(7): 686-692
8. Hsu H S, Wen C K, Tang Y A, et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin Cancer Res, 2005, 11(15): 5410-5416
9. Schildhaus H U, Krockel I, Lippert H, et al. Promoter hypermethylation of p 6INK4a, E-cadherin, 06-MGMT, DAPK and FHlT in adenocarcinomas of the esophagus,esophagogastric junction and proximal stomach. Int J Oncol, 2005, 26(6): 1493-1500
10. Wijermans P W, Krulder J W, Huijgens P C, et al. Continuous infusion of low-dose 5-Aza-2′-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia, 1997, 11(1): 1-5 (Pubitemid 27065040)
11. Momparler R L. Epigenetic therapy of cancer with 5-Aza-2′ -deoxycytidine (decitabine). Semin Oncol, 2005, 32(5): 443-451
12. Zhang Q H, Wang J R, Fan S Q, et al. Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily. FEBS Lett, 2005, 579(17): 3674-3682
13. Zhang Q H, Wang L L, Cao L, et al. Study of a novel brain relatively specific gene LRRC4 involved in glioma tumorigenesis suppression using the Tet-on system. Acta Biochim Biophys Sin (Shanghai), 2005, 37(8): 532-540
14. Wang J R, Li X L, Fan S Q, et al. Chin J Cancer, 2003, 22(9): 897-902
15. Wang J R, Qian J, Dong L, et al. Prog Biochem Biophys, 2002, 29 (2): 233-239